CLINICAL_TRIALS
withdrawal
· 2013-01-24
Clinical Trial Update: A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers [Phase 1]
Summary
A Phase 1 study of AVI-7537 in healthy adult volunteers for Ebola virus disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Ebola Hemorrhagic Fever | Phase 1 | Status: WITHDRAWN